Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx Supply Disruption — Pfizer Inc. (Moderate Risk — T
Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx Supply Disruption — Pfizer Inc. (Moderate Risk — T is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx; Manufacturer: Pfizer
| Drug name | Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx |
|---|---|
| Manufacturer | Pfizer Inc. |
| Recall/Disruption reason | Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lift |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0005-2019 |
| Initiation date | 20180919 |
| Quantity affected | 12,416 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →